CLASTEON

This brand name is authorized in Canada, Israel, Italy, Malta, UK.

Active ingredients

The drug CLASTEON contains one active pharmaceutical ingredient (API):

1	Clodronic acid UNII N030400H8J - CLODRONATE DISODIUM
	Clodronic acid is a bisphosphonate, (formerly diphosphonates), a group of analogues of pyrophosphate, which have been shown, in vitro, to inhibit the formation and dissolution of calcium phosphate (hydroxyapatite). In vivo, they have been shown to inhibit bone resorption to a greater or lesser extent, depending on the compound, and clodronate is one of the most effective in this respect.
	Read more about Clodronic acid

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CLASTEON Capsule	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M05BA02	Clodronic acid	M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BA Bisphosphonates
Discover more medicines within M05BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02245828
GB	Medicines & Healthcare Products Regulatory Agency	115505, 115506, 205406
IL	מִשְׂרַד הַבְּרִיאוּת	8283
IT	Agenzia del Farmaco	026372033, 026372058
MT	Medicines Authority	MA1446/00101